Biotech

All Articles

Editas exploit Tip Cas9 licensing legal rights for $57M

.Versus the backdrop of a Cas9 license struggle that declines to die, Editas Medicine is cashing in ...

Ultragenyx tweaks genetics therapy dosing to call up effectiveness

.A minority of patients taking Ultragenyx Drug's Wilson condition gene therapy UX701 have gone over ...

Biopharma cutback price maintains in Q3: Intense Biotech review

.As summer months warmth counts on cool winds, really hopes that this year will carry extensive busi...

J &amp J goes down phase 2 dengue candidate in newest shift from vaccinations

.Johnson &amp Johnson's deprioritization of its own contagious ailment pipeline has actually claimed...

Relay sheds 10% of staff after earlier layoffs in July

.Precision medication biotech Relay Therapies is actually dropping about 10% of its own workforce in...

Pentixapharm scores $22M IPO to loan radiopharma tests

.Pentixapharm has actually produced nearly twenty thousand euros ($ 22 million) from an IPO, along w...

Lundbeck taps Charles Stream for AI-enabled neuro drug discovery

.Lundbeck has actually tapped Charles Stream Laboratories' expert system functionalities to help the...

Big pharma, biotech 'won't automatically be actually symbiotic' in artificial intelligence: S&ampP

.Huge Pharma is actually investing heavily in artificial intelligence to slash growth timelines as w...

I &amp I biotech Triveni elevates $115M for preclinical antitoxins

.Triveni Bio has actually roped in $115 million in series B funds to advance preclinical antibody pl...

IGM turns coming from cancer cells to autoimmune, shocking C-suite

.IGM Biosciences ended in 2013 giving up team as well as enhancing its own cancer pipe. Now, the bus...